Open AccessCompletion report, Purex and Redox Phase 2 expansion: Jobs 1063 and 1063R. Volume 1
Publication year - 1955
Language(s) - English
Resource type - Reports
DOI - 10.2172/80959
Subject(s) - purex , plutonium , uranium , chemistry , aqueous solution , redox , fission products , third phase , dodecane , transuranium element , aqueous two phase system , extraction (chemistry) , phase (matter) , radiochemistry , solvent extraction , nuclear chemistry , inorganic chemistry , chromatography , materials science , metallurgy , organic chemistry
Vitro Corporation of America entered into a contract with the US Atomic Energy Commission on July 2, 1952 to furnish architect-engineering services in connection with the design and construction of a new chemical plant facility located in the 200 Area of the Hanford Works, Richland, Washington. This contract provided for engineering of facilities utilizing the Purex process to separate and decontaminate uranium and plutonium contained in slugs irradiated in Hanford reactors. Later, Vitro was requested to provide architect-engineering services for an expansion of the previously constructed Redox separation facility. This work, designated as ``Redox Phase II Expansion,`` was authorized by Modification No. 1 to the above contract and was executed April 17, 1953. This completion report has been prepared at the request of the AEC and is intended to provide a convenient source of information concerning the administrative history and engineering features of the Purex plant and the Redox Phase II Expansion